Acute Kidney Injury by Renal Hemosiderosis Secondary to Primary Cold Agglutinin Disease Associated with an Excessive Alcohol Intake-Reference-Cited by-同舟云学术

Acute Kidney Injury by Renal Hemosiderosis Secondary to Primary Cold Agglutinin Disease Associated with an Excessive Alcohol Intake

Published:2018-11-15 Issue:22 Volume:57 Page:3261-3265
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Imafuku Aya¹,Yamamoto Go²,Takemura Koji¹,Hasegawa Eiko¹,Sawa Naoki¹,Kawada Masahiro¹,Sekine Akinari¹,Hoshino Junichi¹,Takaichi Kenmei¹,Fujii Takeshi³,Ohashi Kenichi⁴,Ubara Yoshifumi¹⁵

Affiliation:

1. Nephrology Center, Toranomon Hospital, Japan

2. Hematology Center, Toranomon Hospital, Japan

3. Department of Pathology, Toranomon Hospital, Japan

4. Department of Pathology, Yokohama City University, Graduate School of Medicine, Japan

5. Okinaka Memorial Institute for Medical Research, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/57/22/57_0710-17/_pdf

Reference16 articles.

1. 1. Gelfand JA, Frank MM. Letter: renal failure in paroxysmal hemoglobinuria. JAMA 227: 440, 1974.

2. 2. Chow KM, Lai FM, Wang AY, Chan YL, Tang NL, Li PK. Reversible renal failure in paroxysmal nocturnal hemoglobinuria. Am J Kidney Dis 37: E17, 2001.

3. 3. Qian Q, Nath KA, Wu Y, Daoud TM, Sethi S. Hemolysis and acute kidney failure. Am J Kidney Dis 56: 780-784, 2010.

4. 4. Calazans LM, de Souza, Santos RF, de Souza, Goncalves M, Dos-Santos WL, Rocha PN. Renal hemosiderosis complicating sickle cell anemia. Kidney Int 81: 709, 2012.

5. 5. Ozkurt S, Acikalin MF, Temiz G, Akay OM, Soydan M. Renal hemosiderosis and rapidly progressive glomerulonephritis associated with primary hemochromatosis. Ren Fail 36: 814-816, 2014.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Case of Renal Iron Overload Associated with Cold Agglutinin Disease Successfully Managed by Rituximab;Clinical Hematology International;2023-12-29